Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Chembio Diagnostics Gets Brazilian Regulatory Approval for POC Multiplex Flavivirus Test

Chembio Diagnostics Gets Brazilian Regulatory Approval for POC Multiplex Flavivirus Test

Apr 09, 2019
|
staff reporter

NEW YORK (360Dx) – Chembio Diagnostics said today that it has received Brazilian health agency approval for its DPP Zika/Dengue/Chikungunya point-of-care system in collaboration with Bio-Manguinhos/Fiocruz, a Brazilian government agency and supplier of diagnostic products to the country's Ministry of Health.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  2. Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

  3. SARS-CoV-2 Serology Testing Ramping Up to Address Next Stages of Pandemic

  4. Thermo Fisher Scientific COVID-19 Test Receives CE Mark, Expanded FDA EUA

  5. BioMérieux Rapid Coronavirus Test Gets FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.